SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-152582
Filing Date
2005-07-29
Accepted
2005-07-29 14:53:37
Documents
8
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2005 d10q.htm 10-Q 338378
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION dex31.htm EX-3.1 40987
3 SPECIMEN COMMON STOCK CERTIFICATE dex41.htm EX-4.1 16887
4 CHANGES IN EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS dex101.htm EX-10.1 1620
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9772
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9615
7 CERTIFICATION OF CHIEF EXECUTIVE AND FINANCIAL OFFICERS PURSUANT TO SECTION 906 dex321.htm EX-32.1 4333
8 GRAPHIC g67358img01.jpg GRAPHIC 186652
  Complete submission text file 0001193125-05-152582.txt   680344
Mailing Address 416 BROWNING WAY NONE SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE SUITE 70 SOUTH SAN FRANCISCO CA 94080 6506248200
PAIN THERAPEUTICS INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 05984443
SIC: 2834 Pharmaceutical Preparations